Dr Philip D Hill, DO in Corydon, IN - General Practice

Dr Philip D Hill, DO is a General Practice physician based in Corydon, Indiana. Dr Philip D Hill is licensed to practice in Indiana (license number 02003022A) and his current practice location is 1995 Edsel Ln Nw, Corydon, Indiana. He can be reached at his office (for appointments etc.) via phone at (502) 572-0802.

NPI number for Dr Philip D Hill is 1467600619 and his current mailing address is 4705 Meijer Ct, Lafayette, Indiana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1467600619.

Contact Information

	Dr Philip D Hill, DO
	1995 Edsel Ln Nw, Corydon, IN 47112-3008
	(502) 572-0802
	Not Available

Physician's Profile

Full Name	Dr Philip D Hill
Gender	Male
Speciality	General Practice
Location	1995 Edsel Ln Nw, Corydon, Indiana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1467600619
Provider Enumeration Date: 08/29/2008
Last Update Date: 11/03/2020

Medical Identifiers

Medical identifiers for Dr Philip D Hill such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1467600619	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	02003022A (Indiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Philip D Hill is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Philip D Hill, DO 4705 Meijer Ct, Lafayette, IN 47905-4684 Ph: () -	Dr Philip D Hill, DO 1995 Edsel Ln Nw, Corydon, IN 47112-3008 Ph: (502) 572-0802

News Archive

New metrics needed to evaluate public health response to HIV in the U.S.

A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States.

Ky. Health Plan audit; employee costs in Massachusetts; state reform implementation politics

An organization that manages taxpayer-funded health services for Kentucky's poor and disabled spent freely on luxury hotels, meals, salaries, lobbying and consulting, a state auditor found in a 200-plus-page report which calls for stricter accountability for Passport Health Plan, a Medicaid managed-care provider that serves 164,000 people in Louisville and more than a dozen nearby counties.

Brain imaging indicates potential success of drug therapy in depressive patients

Working with international partners, a MedUni Vienna research group has shown that imaging techniques carried out prior to treatment indicate the potential success of drug therapy in depressive patients.

Splicing factor SRSF6 promotes hyperplasia of sensitized skin

Normally, tissue injury triggers a mechanism in cells that tries to repair damaged tissue and restore the skin to a normal, or homeostatic state. Errors in this process can give rise to various problems, such as chronic inflammation, which is a known cause of certain cancers.

FDA issues Complete Response Letter for CERTRIAD NDA

AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.

Dr Philip D Hill, DO - General Practice in Corydon, IN